Skip to main content

Table 1 Participation of volunteers in the HIVIS-03 trial

From: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial

Volunteers who:

Males (%)

Females (%)

Total (100%)

Attended for Screening

128 (72.3%)

49 (27.7%)

177 (100%)

Screened with available Lab test results

119 (73.5%)

43 (26.5%)

162 (100%)

Randomized

57 (72.2%)

22 (27.8%)

79 (100%)

Exited after Randomization

12 (63.2%)

7 (36.8%)

19 (100%)

Enrolled & received 1st DNA/Placebo vaccination

45 (75%)

15 (25%)

60 (100%)

Screening: Enrolment

2.8:1

3.3:1

3.0:1